Medical Device Industry

Found 5,988 articles

• FDA approves new device to improve symptoms in patients with advanced heart failure

  8/16/2019

  The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.

• Dr. Michael Kaminer Presented Soliton RAP for Cellulite at Key Dermatology Conference

  8/16/2019

  Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), today announced that Dr. Michael Kaminer presented and discussed the company's Rapid Acoustic Pulse technology ("RAP") for the treatment of cellulite at the Controversies and Conversations Symposium, August 9-11, 2019 in San Francisco. 

• BTG receives Health Canada Medical Device License for the ICEfx Cryoablation System

  8/15/2019

  BTG International Canada Inc., part of the global specialist healthcare company BTG plc (LSE: BTG), today announced it has received a medical device license from Health Canada for the ICEfx™ Cryoablation System.

• V-Wave's Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure

  8/15/2019

  V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted the company a Breakthrough Device Designation for its interatrial shunt for Heart Failure (HF).

• Medigate Named to Constellation ShortList for Medical Device Security

  8/15/2019

  Medigate, the first dedicated medical device security and asset management platform, today announced it was named to the Constellation ShortList™ for Medical Device Security in Q3 2019.

• Estar Medical: Regenlab is in Breach of UK Court Orders Following Revocation of its PRP Patent

  8/15/2019

  Regen Lab SA (Regenlab) has failed to pay legal costs ordered by the UK High Court after revocation of its PRP patent for lack of novelty and inventive step. Regenlab is exposed to enforcement procedures which may limit its ability to provide products in the marketplace

• INVO Bioscience Reports Record Second Quarter 2019 Financial Results with Revenue Increasing 498%

  8/14/2019

  INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for its Intravaginal Culture System, INVOcell®, today announced financial results for the second quarter of 2019, ended June 30, 2019.

• Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates

  8/14/2019

  Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today reported financial results for the second quarter ended June 30, 2019 and provided key business updates. 

• Saranas Recognized as One of Houston’s Most Innovative Companies

  8/14/2019

  Saranas Inc. announced that it has been named one of Houston’s most innovative companies.

• Tevosol Closes $2M Seed Round

  8/14/2019

  Tevosol, Inc., an early stage medical device company, today announced it has closed a new round of seed financing for $2 million (CAD)

• Soliton Treats First Patients in Pivotal Cellulite Trial

  8/14/2019

   Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the Company has treated the first patients in its pivotal cellulite trial.

• ivWatch Headquarter Operations Opens Doors on Aug. 16 for Ribbon-Cutting

  8/13/2019

  ivWatch, a biosensor technology company focused on improving patient safety and the effectiveness of intravenous (IV) therapy, will participate in the ribbon-cutting celebration at 10:30 a.m. on August 16, 2019 for the opening of Tech Center Research Park’s Building One

• Feinstein Institutes trial finds promising non-invasive therapy for stroke

  8/13/2019

  Feinstein Institutes for Medical Research scientists are the first to publish clinical trial results of an investigational, non-invasive medical device for the treatment of spasticity in patients having experienced a stroke.

• Electromed, Inc. Schedules Release of Fourth Quarter Fiscal 2019 Financial Results and Conference Call

  8/13/2019

  Electromed, Inc. announced that it will issue its financial results press release for the fiscal 2019 fourth quarter ended June 30, 2019 on Tuesday, August 27, 2019 after the close of the stock market.

• OSF Ventures Joins $35M Funding Round for Handheld Ultrasound Device

  8/12/2019

  OSF Ventures has joined a $35 million funding round to support a start-up that's developing a breakthrough handheld, AI ultrasound device that will allow health care providers to make critical, real-time diagnostic decisions.

• 908 Devices launches the Rebel, the first at-line spent cell media analyzer for bioprocess labs

  8/12/2019

  908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced the launch of their new bioprocess analyzer, the Rebel™

• China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China

  8/12/2019

  Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology called Tumor Treating Fields, today announced that the China National Medical Products Administration (NMPA) granted Innovative Medical Device Designation for Optune

• Encision Reports First Quarter Fiscal Year 2020 Results

  8/12/2019

  Encision Inc. announced financial results for its fiscal 2020 first quarter that ended June 30, 2019.

• Motus GI Reports Second Quarter 2019 Financial Results and Provides Corporate Update

  8/9/2019

  Motus GI Holdings, Inc.,, a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, reported its financial results for the second quarter ended June 30, 2019 and provided a corporate update.

• OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial

  8/9/2019

  OssDsign AB, the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial.